Betulinic Acid Market Size & Outlook, 2026-2034

Betulinic Acid Market Size

The betulinic acid market size was valued at USD 2.5 billion in 2025 and is estimated to reach USD 4.8 billion by 2034, growing at a CAGR of 7.4% during the forecast period (2026-2034). Betulinic acid is getting traction for its immune-supporting and antioxidant benefits. Research highlights that it has as a promising candidate agent for cancer treatments.

Key Market Insights

• North America dominated the market with the largest share of 35% in 2025.
• Asia Pacific is expected to be the fastest-growing region during the forecast period, registering a CAGR of 7.8%.
• By type, the natural betulinic acid dominated the market with a 57.2% revenue share in 2025.
• By application, the pharmaceutical segment held the largest share of 55% in 2025.
• The US betulinic acid market size was valued at USD 0.95 billion in 2025 and is projected to be USD 1.5 billion in 2026.

To get more insights about this report Download Free Sample Report

Betulinic Acid Market Trends

Increasing Research on Potent Anti-tumor Properties

There is growing scientific evidence for the therapeutic potential of betulinic acid. It has shown selective cytotoxicity against tumor cells through apoptosis induction, sparing healthy tissues while targeting melanoma, glioblastoma, and pancreatic cancers. This has led to rising academic biotech research focused on understanding its mechanisms of action and developing formulations and derivatives for oncology applications. Scientists are conducting more research on how betulinic acid slows down the growth of tumor cells or triggers their death while causing less harm to normal healthy cells compared to many chemical cancer drugs. A study conducted by the School of Life Sciences and Health Engineering, Jiangnan University, found that betulinic acid significantly suppressed melanoma tumor growth.

Inclination toward Anti-aging and UV-protective Cosmetic Products

The sudden surge of betulinic acids in cosmetics is due to their proven anti-aging, anti-inflammatory, and UV-protective properties. Consumers also prefer clean labels and herbal, chemical-free skincare products. Companies are now adding betulinic acid to creams, lotions, and serums. In nutraceuticals, it is getting traction for its immune-supporting, metabolic health, and antioxidant benefits. This expanding application is encouraging manufacturers to develop high-purity, cosmetic- and nutraceutical-grade betulinic acid while driving innovation in formulation compatibility and bioavailability.

Betulinic Acid Market Drivers

Increasing Base of Health-conscious Consumers to Drive Demand for Food and Botanical Supplements

Consumers worldwide are shifting toward preventive healthcare; thus, reliance on food supplements is growing. There has been a surge in the use of betulinic acid due to its antioxidant, anti-inflammatory, metabolic support, and immune-boosting properties. This makes it attractive for consumers seeking plant-based health products. Rising awareness of lifestyle-related disorders and the demand for clean botanical supplements are boosting the market. Betulinic acid combined with natural ingredients, such as green tea extract, curcumin, or resveratrol, enhances overall wellness benefits.

Growing Preference for Improved Extraction and Use of Green Solvents to Support Growth

Supercritical CO₂ extraction separates betulinic acid at high purity without using toxic organic solvents under controlled temperature and pressure conditions. Green solvents, such as ethanol, water-based mixtures, and natural deep eutectic solvents, support the efficient extraction and purification. The green solvent ensures that the final ingredient meets clean label expectations and regulatory safety limits.

Market Restraints

Scalability and Supply Chain Challenges to Limit Widespread Use of Betulinic Acid

Betulinic acid strongly relies on natural raw materials and complex extraction processes. Since the raw materials are sourced naturally, they face barriers such as geographic limitations, seasonal harvesting cycles, and forestry regulations. This, in turn, leads to scalability issues for manufacturers. High-purity extraction and purification require advanced technology, skilled labor, and multiple processing steps. Lack of technology or limited/unskilled human capital can restrict extraction capabilities, leading to supply shortages and price volatility.

Market Opportunities

Development of Advanced Delivery Systems for Enhanced Therapeutic Applications to Present Lucrative Opportunities

Bioactive ingredients can be encapsulated in advanced delivery systems such as nanoparticles and liposomes, which protect it from degrading and improve solubility to reach target cells more efficiently. Targeted delivery of nanoparticles reduces major side effects, such as accumulation of formulation in organs and altered pharmacokinetics. These delivery methods enhance oral absorption so that more active compound enters the bloodstream and provides measurable health benefits. For example, Camurus AB, a biotech company, specializes in lipid nanocarriers and injectables for small molecules. Tiba Biotech offers biodegradable nanoparticle systems to enhance targeted delivery.

Technological Landscape

• Formulator Online is a cloud-based and compliance-based platform to store ingredient data and build formulas, which makes it easier to track the inclusion and role of active ingredients.
• Design-Expert software optimizes extraction from birch bark by statistically modeling solvent concentration, extraction temperature, time, and solid-to-liquid ratio.
• Minitab Statistical Software is used by natural ingredient manufacturers for batch-to-batch consistency monitoring.

Regional Analysis

The betulinic acid market in North America had a market share of 35% in 2025. The growth is driven by strong pharmaceutical R&D capabilities and well-established cosmetics and nutraceutical industries. With increasing investments in cancer research focused on curbing tumor growth, triggering cancer cell death, and reducing metastasis, the region boasts of robust medical infrastructure. The American Cancer Society awarded 92 research grants in 2025, totaling USD 43.2 million. The region also has highly developed cosmetics and neurological industries, with a strong consumer preference for natural, plant-based ingredients.

The US is the fastest-growing country in North America, growing at a CAGR of 6.9% during the forecast period. US companies and research labs are actively focusing on advanced delivery systems such as nanoparticles and liposomes to overcome solubility and bioavailability limitations. Clear regulatory pathways for dietary supplements, cosmetic ingredients, and early-stage drug research make the US an attractive market for scaling and making betulinic acid-based products.

Europe

Europe held around 25% of the market share in 2025. Betulinic acid aligns well with European market preferences due to its plant-derived origin and multifunctional bioactivity. The region has a strict regulatory framework, such as REACH, which requires detailed chemical characterization, safety testing, and traceability. The legislation encourages the manufacturers to produce high-purity, well-characterized bioactive ingredients. European companies heavily focus on innovation, bioavailability, and product combinations.

Germany is expected to have considerable growth in the European region with a CAGR of 6.3%. German consumers are highly conscious and prefer plant-based and clinically supported ingredients. There are companies in Germany, such as Dermapharm AG, which emphasize innovation and R&D in natural and multifunctional formulants. Certification and labeling standards such as Cosmetic Organic and Natural Standard (COSMOS) help verify that the products are truly natural or organic and build consumer trust.

Asia Pacific

Asia Pacific accounted for 20% of the market share in 2025, owing to large-scale extraction and manufacturing facilities to produce high-purity bioactive compounds. The personal care industry in the Asia Pacific is currently growing rapidly, as consumers prefer plant-based, multifunctional, and safe ingredients. Developing countries in this region are also exhibiting initiatives to integrate modern products in treatments. For instance, the Ayush Promotion Policy by the Government of India aims to integrate traditional medicines with modern wellness products.

China is expected to grow at a CAGR of 7.2% during the forecast period. China combines traditional medicines with modern nutraceutical and pharmaceutical R&D. It is also investing in pharmaceutical and bioactive research. For instance, a December 2025 study revealed co-delivery systems with betulinic acid for cancer immunotherapy. The country also has ample raw materials to scale up production due to the presence of birch-producing areas, such as Northeast China. These factors make China a leading country in the Asia Pacific market.

Latin America

Latin America held 15% of the global market share in 2025. The region has rich biodiversity and plant-based raw materials, which makes it suitable for extracting bioactive compounds. The availability of raw materials enables both local production and export, lowering costs and market growth. Consumers have also started showing interest in herbal supplements, which encourages companies to incorporate bioactive compounds.

Brazil is experiencing considerable growth in the Latin American region, with a CAGR of 6.8% during the forecast period. Brazil provides many sources of plant compounds due to an abundance of natural resources. The Brazilian Health Regulatory Agency plays a vital role in the regulatory framework for herbal supplements and cosmetic products. The country has a growing focus on bioactive therapeutic research, an established natural product industry, and a growing trend toward functional health ingredients. 

Middle East & Africa

The Middle East & Africa region accounted for 5% of market share in 2025. The region heavily relies on imports of premium nutraceuticals and cosmetic products from Europe, North America, and Asia Pacific. The imports often feature bioactive ingredients, helping to introduce and expand their market presence.

South Africa is the fastest-growing country in the Middle East & Africa region, with a CAGR of 6.5% during the forecast period. South Africa has a diverse flora, which makes it suitable for extracting natural bioactive. In 2025, South Africa launched a National Action Plan (NAP) to prevent substandard and fake medical products by monitoring supply chain and traceability across health sectors.

Type Insights

The natural betulinic acid segment accounted for the largest market share in 2025. Strong consumer preference for plant-derived compounds and sustainability aligns well with natural, clean-label, and sustainable ingredients. Natural betulinic acid is widely used in cosmetics, nutraceuticals, and pharmaceutical applications as a safer and more environmentally friendly alternative.

The synthetic betulinic acid segment is expected to grow at a CAGR of 10% during the forecast period. The growth is driven by drug development activities and rising pharmaceutical research. This acid is used in clinical research and advanced medical applications due to its purity, consistent quality, and scalability features.

Figure: Betulinic Acid Market Segments

Application Insights

The pharmaceutical applications segment holds the largest market share, accounting for 55% of total revenue in 2025. This segment is driven by extensive use of betulinic acid in drug development for anti-cancer, anti-inflammatory, and anti-viral properties. It can target diseased cells and comparatively cause less damage to healthy cells. Bioactive properties are highly valued by companies and researchers. Ongoing clinical research and studies further strengthen the role of betulinic acid in the pharmaceutical sector.

The cosmetics application segment is projected to grow at a CAGR of 7.5% during the forecast period. Natural active ingredients are incorporated into anti-aging, skin-smoothing, and repair-focused skincare products due to increasing inclination toward looking more youthful. With consumers becoming more selective, their awareness of clean-label ingredients is also increasing. Thus, the boost to the cosmetics industry is expected to propel market growth during the forecast period.

Regulatory Bodies Governing Betulinic Acid Market

List of key players in Betulinic Acid Market

1. Manus Aktteva Biopharma LLP
2. Aktin Chemicals Inc.
3. Capot Chemical Co. Ltd.
4. Tokyo Chemical Industry Co. Ltd.
5. Cayman Chemical
6. Toronto Research Chemicals
7. Glentham Life Sciences
8. Bionov
9. Symrise BioActives GmbH
10. Croda International Plc
11. Alba Volka Group
12. Adooq Bioscience
13. Huanwei Biotech
14. Vytrus Biotech
15. Hunan Nutramax Inc.
16. Shaanxi Pioneer Biotech
17. BioVision Inc.
18. Plamed Green Science Group
19. Tianjin NWS
20. Kono Chem Co. Ltd.
21. Greenleaf

To get more findings about this report Download Market Share

Recent Developments

Source: Secondary Research

Latest News on Emerging Market Player

Source: Secondary Research